These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 23692281)

  • 1. Characterization of novel CD55 isoforms expression in normal and neoplastic tissues.
    Vainer ED; Meir K; Furman M; Semenenko I; Konikoff F; Vainer GW
    Tissue Antigens; 2013 Jul; 82(1):26-34. PubMed ID: 23692281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor.
    Osuka F; Endo Y; Higuchi M; Suzuki H; Shio Y; Fujiu K; Kanno R; Oishi A; Terashima M; Fujita T; Gotoh M
    Genomics; 2006 Sep; 88(3):316-22. PubMed ID: 16503113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decay-accelerating factor in the periovulatory rat ovary.
    Gieske MC; Na GY; Koo Y; Jo M; Curry TE; Ko C
    J Endocrinol; 2005 Aug; 186(2):303-13. PubMed ID: 16079256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.
    Oyama S; Fujino H; Yamazaki R; Okura I; Regan JW; Awata A; Arai T; Murayama T
    Arch Biochem Biophys; 2014 Jan; 541():21-9. PubMed ID: 24239863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decay accelerating factor (CD55): a target for cancer vaccines?
    Spendlove I; Li L; Carmichael J; Durrant LG
    Cancer Res; 1999 May; 59(10):2282-6. PubMed ID: 10344729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor.
    Kawada M; Mizuno M; Nasu J; Uesu T; Okazaki H; Okada H; Shimomura H; Yamamoto K; Tsuji T; Fujita T; Shiratori Y
    J Lab Clin Med; 2003 Nov; 142(5):306-12. PubMed ID: 14647034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and functional analysis of mouse decay accelerating factor (CD55).
    Harris CL; Rushmere NK; Morgan BP
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD55 is over-expressed in the tumour environment.
    Li L; Spendlove I; Morgan J; Durrant LG
    Br J Cancer; 2001 Jan; 84(1):80-6. PubMed ID: 11139317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TIMP-1 splice variant transcript: possible role in regulation of TIMP-1 expression.
    Obro NF; Lademann U; Birkenkamp-Demtroder K; Holten-Andersen L; Brünner N; Offenberg H
    Cancer Lett; 2008 Apr; 262(1):64-70. PubMed ID: 18180096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
    Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
    Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL; Jones A; Norman S; Holmes CH
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.
    Heine H; Ulmer AJ; El-Samalouti VT; Lentschat A; Hamann L
    J Endotoxin Res; 2001; 7(3):227-31. PubMed ID: 11581575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional differences among multiple isoforms of guinea pig decay-accelerating factor.
    Wang G; Nonaka M; He C; Okada N; Nakashima I; Okada H
    J Immunol; 1998 Mar; 160(6):3014-22. PubMed ID: 9510206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
    Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
    Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel protein isoforms of carcinoembryonic antigen are secreted from pancreatic, gastric and colorectal cancer cells.
    Hatakeyama K; Wakabayashi-Nakao K; Ohshima K; Sakura N; Yamaguchi K; Mochizuki T
    BMC Res Notes; 2013 Sep; 6():381. PubMed ID: 24070190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).
    Hinchliffe SJ; Spiller OB; Rushmere NK; Morgan BP
    J Immunol; 1998 Nov; 161(10):5695-703. PubMed ID: 9820551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.